106 related articles for article (PubMed ID: 8457478)
1. Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo.
Higgins JA; Giangrande PL; Kernoff PB; Goodall AH
Br J Haematol; 1993 Feb; 83(2):296-305. PubMed ID: 8457478
[TBL] [Abstract][Full Text] [Related]
2. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
[TBL] [Abstract][Full Text] [Related]
3. Effect of intermediate- and high-purity factor VIII concentrates on immune function in HIV-seropositive haemophiliacs as assessed by quantitative CD 4 counts.
Deitcher SR; Tuller J; Dugdale M
Haemophilia; 1997 Oct; 3(4):265-9. PubMed ID: 27214862
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].
Lorenzo JI; Molina R; Aznar JA
Sangre (Barc); 1993 Feb; 38(1):5-11. PubMed ID: 8470035
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the aetiological role of blood-borne virus infections in causing reduced lectin-induced T-cell proliferation in haemophilic boys.
Evans JA; Pasi KJ; Hill FG
Br J Haematol; 1995 Sep; 91(1):197-202. PubMed ID: 7577632
[TBL] [Abstract][Full Text] [Related]
7. PCR analysis of HIV-1 sequences and differential immunological features in seronegative and seropositive haemophiliacs.
Chelucci C; Hassan HJ; Gringeri A; Macioce G; Mariani G; Santagostino E; Testa U; Vulcano F; Mannucci PM; Peschle C
Br J Haematol; 1992 Aug; 81(4):558-67. PubMed ID: 1390244
[TBL] [Abstract][Full Text] [Related]
8. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy.
Cuthbert RJ; Ludlam CA; Steel CM; Beatson D; Peutherer JF
Br J Haematol; 1992 Mar; 80(3):364-9. PubMed ID: 1581216
[TBL] [Abstract][Full Text] [Related]
9. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
Gjerset GF; Pike MC; Mosley JW; Hassett J; Fletcher MA; Donegan E; Parker JW; Counts RB; Zhou Y; Kasper CK
Blood; 1994 Sep; 84(5):1666-71. PubMed ID: 7915149
[TBL] [Abstract][Full Text] [Related]
10. [Effect of factor VIII concentrates of very high purity on CD4+ cell count in hemophiliacs infected with HIV].
Molina Alejandro R; Lorenzo Herrero JI; Haya Guaita S; Querol Fuentes F; Aznar Lucea JA
Rev Clin Esp; 1996 Jun; 196(6):365-9. PubMed ID: 8767071
[TBL] [Abstract][Full Text] [Related]
11. Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.
Hilgartner MW; Buckley JD; Operskalski EA; Pike MC; Mosley JW
Lancet; 1993 May; 341(8857):1373-4. PubMed ID: 8098792
[TBL] [Abstract][Full Text] [Related]
12. The impact of a very high-purity factor VIII concentrate on the immune system of HIV-infected haemophiliacs: a randomized, two-year comparison with a high-purity concentrate.
de Biasi R; Rocino A; Quirino AA; Miraglia E; Ziello L
Haemophilia; 1996 Apr; 2(2):82-7. PubMed ID: 27214013
[TBL] [Abstract][Full Text] [Related]
13. CD4+ counts before and after switching to monoclonal high-purity factor VIII concentrate in HIV-infected haemophilic patients.
Sabin C; Pasi J; Phillips A; Elford J; Janossy G; Lee C
Thromb Haemost; 1994 Aug; 72(2):214-7. PubMed ID: 7831654
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. II. Improvements of CD4/CD8 ratio after treatments with heat-inactivated factor concentrates.
Shen MC; Hu FC; Lin JS; Tsai W; Fon MF; Wang EC
Haemophilia; 1998 Jan; 4(1):33-40. PubMed ID: 9873863
[TBL] [Abstract][Full Text] [Related]
15. High versus ultra-high purity factor VIII concentrate therapy: prospective evaluation of immunological and clinical parameters in HIV seronegative and seropositive hemophiliacs.
Varon D; Schulman S; Dardik R; Barzilai A; Bashari D; Martinowitz U
Thromb Haemost; 1994 Sep; 72(3):359-62. PubMed ID: 7855784
[TBL] [Abstract][Full Text] [Related]
16. Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y).
Evans JA; Pasi KJ; Williams MD; Hill FG
Br J Haematol; 1991 Nov; 79(3):457-61. PubMed ID: 1751373
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of immunological abnormalities in Korean hemophiliacs.
Kim KY; Yang CH; Kang SH; Kim DS
Yonsei Med J; 1989; 30(2):180-5. PubMed ID: 2508331
[TBL] [Abstract][Full Text] [Related]
18. HIV antibody status and immunological abnormalities in Polish haemophiliacs.
Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H
Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899
[TBL] [Abstract][Full Text] [Related]
19. [HIV infection and immunity disorders in patients with hemophilia].
Gotić M; Rolović Z; Brkić S; Vucković S; Bujko M; Lilić D; Dujić A
Srp Arh Celok Lek; 1989; 117(11-12):737-50. PubMed ID: 2490991
[TBL] [Abstract][Full Text] [Related]
20. Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Mannucci PM; Gringeri A; de Biasi R; Baudo F; Morfini M; Ciavarella N
Thromb Haemost; 1992 Mar; 67(3):310-3. PubMed ID: 1353642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
